These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6762722)

  • 21. Cyclosporine kinetics in pediatric patients with congestive heart failure.
    Burckart GJ; Fricker FJ; Venkataramanan R; Ptachcinski RJ; Hardesty RL; Trento A; Howrie DL; Griffith BP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1528-9. PubMed ID: 3274373
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation.
    Savoldi S; Scolari F; Sandrini S; Scaini P; Sacchi G; Tardanico R; Camerini C; Salerni B; Tonini G; De Nobili U
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):777-84. PubMed ID: 3291313
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies.
    Whiting PH; Thomson AW; Simpson JG
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):134-44. PubMed ID: 3895654
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction between phenytoin and cyclosporine following organ transplantation.
    Keown PA; Laupacis A; Carruthers G; Stawecki M; Koegler J; McKenzie FN; Wall W; Stiller CR
    Transplantation; 1984 Sep; 38(3):304-6. PubMed ID: 6474556
    [No Abstract]   [Full Text] [Related]  

  • 26. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.
    Wood AJ; Lemaire M
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):27-32. PubMed ID: 3895666
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporine nephrotoxicity and cyclosporine--digoxin interaction prior to heart transplantation.
    Dorian P; Cardella C; Strauss M; David T; East S; Ogilvie R
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1825-7. PubMed ID: 3274430
    [No Abstract]   [Full Text] [Related]  

  • 29. Nephrotoxicity of cyclosporine in liver transplantation.
    Iwatsuki S; Esquivel CO; Klintmalm GB; Gordon RD; Shaw BW; Starzl TE
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):191-5. PubMed ID: 3895661
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of cyclosporine A on long-term renal function in pediatric liver transplant recipients.
    Andrews WA; Arant BS; Fyock B; Gray S; Schlatter MG; Conlin C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1452-3. PubMed ID: 1989261
    [No Abstract]   [Full Text] [Related]  

  • 31. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
    Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporine A-induced side effects related to a low total serum cholesterol level: an indication for a free cyclosporine A assay?
    de Groen PC; Wiesner RH; Krom RA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):374-6. PubMed ID: 3284081
    [No Abstract]   [Full Text] [Related]  

  • 34. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.
    Block LH; Sutter PM; Mihatsch MJ
    Klin Wochenschr; 1983 Nov; 61(21):1053-62. PubMed ID: 6358655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine levels are not helpful.
    Henry ML; Bowers VD; Fanning WJ; Sommer BG; Ferguson RM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):419-21. PubMed ID: 3284086
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of mode of pretransplant loading with cyclosporine on the incidence of early rejection in haploidentical living related donor renal recipients.
    Kahan BD; Wideman C; Gibbons S; Ried M; Jarowenko M; Flechner S; Van Buren CT
    Transplant Proc; 1984 Dec; 16(6):1619-23. PubMed ID: 6390876
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporine measurement in transplantation.
    Sanghvi A; Seltman H; Diven W
    Arch Pathol Lab Med; 1985 Dec; 109(12):1072-5. PubMed ID: 3907588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation.
    Venkataramanan R; Burckhart GJ; Ptachcinski RJ
    Semin Liver Dis; 1985 Nov; 5(4):357-68. PubMed ID: 3909430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.